Synthesis and biological evaluation of some new 1,3,4-thiadiazole and 1,2,4-triazole derivatives from L-methionine as antituberculosis and antiviral agents L-Metiyoninden hareketle elde edilen bazı yeni 1,3,4-tiyadiazol ve 1,2,4-triazol türevlerinin sentezi, antitüberküler ve antiviral etkilerinin değerlendirilmesi

Creative Commons License

TATAR E., KÜÇÜKGÜZEL Ş. G. , KARAKUŞ S., De Clercq E., Andrei G., Snoeck R., et al.

Marmara Pharmaceutical Journal, cilt.19, ss.88-102, 2015 (SCI Expanded İndekslerine Giren Dergi) identifier

  • Cilt numarası: 19 Konu: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.12991/mpj.2015199639
  • Dergi Adı: Marmara Pharmaceutical Journal
  • Sayfa Sayısı: ss.88-102


Some novel 1,3,4-thiadiazole [5-8] and 1,2,4-triazole [9-12] derivatives carrying amino acid moiety were synthesized starting from L-methionine. 1,3,4-Thiadiazole and 1,2,4-triazole scaffolds were prepared by cyclocondensation of the corresponding thiosemicarbazide and finally converted to their thiourea derivatives. Structures of the synthesized compounds [4-12] were confirmed by IR, H-1-NMR and C-13-NMR spectral data and elemental analysis. Synthesized compounds were evaluated for their antiviral and antibacterial activity. Of the screened compounds, N-{3-(methylsulfanyl)1-[5-(phenylamino)-1,3,4-thiadiazole-2-yl] propyl} benzamide 5] was identified as the most potent inhibitor of Influenza A H3N2 virus with an EC50 value of 31.4 mu M, which serves as a lead compound for prospective development. The antituberculosis activity screen of the synthesized compounds revealed